跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“MRGPRX4”
全部
16
临床试验
0
药物
7
机构
0
资讯
9
去年
Incyte Halts MRGPRX2 Trial, Discontinues MRGPRX4 Program Following Unfavorable Results
去年
Incyte Halts Development of Cholestatic Pruritus Drug and Pauses Urticaria Trial
去年
Incyte Halts Development of MRGPRX2 Inhibitor INCB000262 Following Preclinical Toxicology Findings
去年
Incyte and iTeos Terminate Development of Zilurgisertib and Inupadenant Following Disappointing Trial Data
去年
Evommune's MRGPRX2 Antagonist EVO756 Shows Promise in Chronic Urticaria Trials
9天前
Evommune's Oral MRGPRX2 Antagonist EVO756 Fails Phase 2b in Atopic Dermatitis, Program Halted
11个月前
Evommune Files for $100M IPO to Advance Novel MRGPRX2-Targeting Drug for Chronic Urticaria
7个月前
Septerna Advances MRGPRX2 Inhibitor SEP-631 to Clinical Testing for Chronic Urticaria and Mast Cell Disorders
去年
Evommune Initiates Phase 2b Trial of Oral MRGPRX2 Antagonist EVO756 for Moderate to Severe Atopic Dermatitis